17 insiders reported 163 Form 4 transactions for Entrada Therapeutics, Inc. (TRDA) over the past 18 months (most recent 2026-05-21). Recent activity: Zeiher Bernhardt G (Director) Buy 5,000 shares, WENTWORTH KORY JAMES (Chief Financial Officer) Sell 2,500 shares, Dowden Nathan J (President & COO) Sell 11,894 shares, WENTWORTH KORY JAMES (Chief Financial Officer) Sell 11,388 shares, Dowden Nathan J (President & COO) Sell 3,116 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-21 | Zeiher Bernhardt G | Director | Buy | 5,000 | $29,316 |
| 2026-04-02 | WENTWORTH KORY JAMES | Chief Financial Officer | Sell | 2,500 | $32,375 |
| 2026-03-11 | Dowden Nathan J | President & COO | Sell | 11,894 | $155,217 |
| 2026-03-11 | WENTWORTH KORY JAMES | Chief Financial Officer | Sell | 11,388 | $148,272 |
| 2026-03-11 | Dowden Nathan J | President & COO | Sell | 3,116 | $40,570 |
| 2026-03-11 | WENTWORTH KORY JAMES | Chief Financial Officer | Sell | 5,089 | $66,157 |
| 2026-03-06 | WENTWORTH KORY JAMES | Chief Financial Officer | Sell | 7,988 | $97,853 |
| 2026-03-03 | Sethuraman Natarajan | President, Research & Develop. | Buy | 55,800 | $0 |
| 2026-03-03 | Sethuraman Natarajan | President, Research & Develop. | Sell | 3,898 | $45,451 |
| 2026-03-03 | Sethuraman Natarajan | President, Research & Develop. | Sell | 7,577 | $89,106 |
| 2026-03-03 | WENTWORTH KORY JAMES | Chief Financial Officer | Buy | 44,600 | $0 |
| 2026-03-03 | WENTWORTH KORY JAMES | Chief Financial Officer | Sell | 2,939 | $34,269 |
| 2026-03-03 | Doshi Dipal | CEO | Buy | 139,400 | $0 |
| 2026-03-03 | Doshi Dipal | CEO | Sell | 9,869 | $115,073 |
| 2026-03-03 | Doshi Dipal | CEO | Sell | 19,181 | $225,569 |
| 2026-03-03 | Dowden Nathan J | President & COO | Buy | 55,800 | $0 |
| 2026-03-03 | Dowden Nathan J | President & COO | Sell | 7,223 | $84,220 |
| 2026-03-03 | Dowden Nathan J | President & COO | Sell | 14,038 | $165,087 |
| 2026-03-03 | WENTWORTH KORY JAMES | Chief Financial Officer | Sell | 5,712 | $67,173 |
| 2025-11-24 | BAKER BROS. ADVISORS LP | Insider | Buy | 13,386 | $121,411 |
| 2025-11-24 | BAKER JULIAN | Insider | Buy | 1,213 | $11,002 |
| 2025-11-24 | Baker Bros. Advisors (GP) LLC | Insider | Buy | 1,213 | $11,002 |
| 2025-11-24 | BAKER BROS. ADVISORS LP | Insider | Buy | 1,213 | $11,002 |
| 2025-11-24 | BAKER FELIX | Insider | Buy | 1,213 | $11,002 |
| 2025-11-24 | Baker Bros. Advisors (GP) LLC | Insider | Buy | 13,386 | $121,411 |
Source: SEC Form 4 filings · as of 2026-05-21